뉴스벤징가
FDA Declines To Approve Achieve Life Sciences' Smoking Cessation Drug; Q4 Resubmission Planned
· 발표
기사 요약
FDA rejects Achieve Life Sciences application for cytisinicline tied to manufacturing issues, with NDA resubmission planned in Q4 2026.
기사 원문에서 발췌했어요.
댓글 —
댓글을 불러오고 있어요…